GRIN Therapeutics, Inc.
GRIN Therapeutics, Inc.
Explore linked clinical trials.4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder | GRIN-related complex neurodevelopmental disorder | Recruiting | Phase 3 | 2026-07-17 | NCT07224581 | |
| Radiprodil in Participants With Hepatic Impairment | Hepatic Impairment | Recruiting | Phase 1 | 2026-05-08 | NCT07457229 | |
| Astroscape: A Study of Radiprodil on Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms in Patients With TSC or FCD Type II | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Focal Cortical Dysplasia, Malformations of Cortical Development, Group I, Neoplasms, Multiple Primary, central nervous system malformation, cerebral cortical dysplasia, hamartoma, hereditary disease, hereditary neoplastic syndrome, inherited neurodegenerative disorder, neoplasm, nervous system disorder, neurocutaneous syndrome, neurodegenerative disease, tuberous sclerosis | Active, not recruiting | Phase 1 / Phase 2 | 2026-04-01 | NCT06392009 | |
| Honeycomb: Evaluation of Radiprodil in Children with GRIN-related Disorder | GRIN-related Disorders | Active, not recruiting | Phase 1 | 2024-11-15 | NCT05818943 |